Trial Profile
A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of erectile dysfunction (ED) with an open label extension
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2023
Price :
$35
*
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Futura Medical
- 12 Jun 2023 According to a Futura Medical media release, based on results from this trial the MED3000 has been granted a CE Mark in 2021 for treatment of Erectile-dysfunction.
- 07 Jun 2020 This trial has been discontinued in Latvia, according to European Clinical Trials Database record.
- 02 Apr 2020 Results presented in a Futura Medical media release.